India to make vaccines for Indo-Pacific region

Indian Prime Minister Narendra Modi, US President Joe Biden, Australian Prime Minister Scott Morrison and Japanese Prime Minister Yoshihide Suga came together in a virtual meeting of the “Quad” group of nations that is central to efforts to counter China’s growing military and economic power.
The group, meeting on Friday, decided to launch a mega vaccine initiative under which coronavirus vaccines will be produced in India for the Indo-Pacific region – in an effort to counter Chinese influence – with financial assistance from the US and Japan while Australia will contribute in logistical aspects.

“PM Modi, it’s great to see you,” President Biden said as the two leaders met for the first time since the new administration took charge after the November US election. Modi, in his opening remarks, said the four countries were united by their democratic values and that the Quad would remain an important pillar of stability in the Indo-Pacific region.

“We are united by our democratic values, and our commitment to a free, open and inclusive Indo-Pacific. Our agenda today – covering areas like vaccines, climate change and emerging technologies – makes the Quad a force for global good,” said the Prime Minister.

“We will work together, closer than ever before, for advancing our shared values and promoting a secure, stable and prosperous Indo-Pacific. Today’s summit meeting shows that Quad has come of age. It will now remain an important pillar of stability in the region,” he added.

President Biden, opening the meeting, said the Quad would be a vital arena for cooperation and a free and open Indo-Pacific region was essential to all of their futures. “We know our commitments…Our region is governed by international law, committed to all the universal values and free from coercion but I am optimistic about our prospect,” he said, in an apparent reference to China.

“The United States is committed to working with you and with all our allies in the region to achieve stability. This group is particularly important because it is dedicated to the practical solutions and concrete results,” the US President added.

Briefing reporters on the summit, Foreign Secretary Harsh Vardhan Shringla said it was decided that India’s manufacturing capacity is something that is going to be leveraged to make COVID-19 vaccines. “The aim is to produce a billion doses by the end of 2022,” he said.